SAN FRANCISCO On Sunday, Alnylam, the gene-silencing company that notched one gigantic accomplishment after another over the past five years, set out a plan for the next five years built on yet more… [+1190 chars]Read More
Alnylam charts ambitious fiveyear plan as sales of key drug miss expectations statnewscom
